- Our Doctors
- Dr Sheena Khanduri
Dr Sheena Khanduri
MB BChir, MA (Cantab) MRCP, FRCR
Languages spoken
English
Expert in
Breast cancer
Overview
Centres
Specialises in
Treatments
About Dr Khanduri
Dr Khanduri qualified at Cambridge University and is an experienced Clinical Oncologist specialising in breast cancer radiotherapy.
She was Executive Medical Director and Responsible Officer at The Clatterbridge Cancer Centre NHS Foundation Trust from 2017, where she oversaw the transformation of oncology services - including the opening of a new cancer hospital and significant growth in research.
Dr Khanduri joined GenesisCare as Chief Medical Officer UK in 2025. Her clinical expertise, leadership experience, and deep commitment to patient-centred care make her ideally placed to lead our medical teams across the UK. She is passionate about delivering high quality patient care, developing clinical leadership and using technology to drive meaningful progress in cancer treatments, patient care and clinical outcomes.
Professional memberships:
- Fellow of Royal College of Radiologists
- Member of the British Medical Association
Publications:
- Breast J. 2022 Hall BJ, Bhojwani AA, Wong H, Law A, Flint H, Ahmed E, Innes H, Cliff J, Malik Z, O'Hagan JE, Hall A, Sripadam R, Tolan S, Ali Z, Hart C, Errington D, Alam F, Giuliani R, Mehta S, Khanduri S, Thorp N, Jackson R, Cicconi S, Palmieri C. Neoadjuvant Trastuzumab and Pertuzumab for Early HER2-Positive Breast Cancer: A Real World Experience. Breast J. 2022 Jun 30;2022:7146172. doi: 10.1155/2022/7146172. PMID: 35833190; PMCID: PMC9262537.
- 2019 UKIO: Increasing recruitment to research studies by strategic support, engagement and diversification of the research portfolio to support service department delivery M. Maguire, S. Khanduri
- 2018 Abstract UKRCO: Axillary radiotherapy for breast cancer minimises overtreatment and has a low complication rate B Lake 1; S Khanduri 2; A Welsh 1; G Wardle 1; L Pettit 1 1Shrewsbury & Telford NHS Trust; 2Clatterbridge Cancer Centre NHS Foundation Trust
- 2017 abstract and oral presentation: International Digital Health and Care Congress, Kings Fund: Digital technology improves monitoring of chemotherapy toxicity and enhances citizen self-care, S Khanduri, R Redgrave, A Elves, L Breakell, K Fleming
- 2016 Abstract: UKONS A Digital Health solution to enable chemotherapy patients to Self-Manage their Condition R Redgrave, S Khanduri, A Cooper, A Elves